Inactive Instrument
Capstone Therapeutics Corp Share Price Other OTC
Stocks
US14068E1091
Construction Materials
| Market Cap | 3.14M 2.75M 2.56M 2.36M 4.42M 300M 4.49M 30.41M 11.9M 149M 11.77M 11.52M 513M | P/E 2026 * |
1.24x | P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 3.14M 2.75M 2.56M 2.36M 4.42M 300M 4.49M 30.41M 11.9M 149M 11.77M 11.52M 513M | EV / Sales 2026 * |
0.04x | EV / Sales 2027 * | - |
| Free-Float |
57.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +11.54% |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Lipman
CEO | Chief Executive Officer | 47 | 01/12/2024 |
Edward Schultz
DFI | Director of Finance/CFO | 42 | 24/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Jock Holliman
CHM | Chairman | 73 | 04/04/2006 |
Michael Toporek
CHM | Chairman | 62 | - |
Matthew Lipman
BRD | Director/Board Member | 47 | 13/07/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +11.54% | -.--% | - | - | 3.14M | ||
| -1.61% | -7.58% | +301.32% | +237.19% | 1.78B | ||
| +2.68% | +2.71% | +26.85% | +108.18% | 1.43B | ||
| -1.06% | -6.57% | -17.23% | +16.60% | 931M | ||
| +3.64% | 0.00% | -8.80% | -30.91% | 553M | ||
| +0.74% | +6.27% | -22.35% | -23.88% | 403M | ||
| +1.93% | -0.49% | +18.14% | +40.63% | 224M | ||
| +2.81% | +1.93% | +9.57% | -4.23% | 190M | ||
| -1.44% | -3.62% | - | - | 177M | ||
| +3.73% | -4.58% | +81.16% | +362.96% | 154M | ||
| Average | +2.30% | -2.10% | +48.58% | +88.32% | 649.68M | |
| Weighted average by Cap. | +0.62% | -2.06% | +99.53% | +111.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.11M 63.29M 58.93M 54.2M 102M 6.89B 103M 699M 274M 3.42B 271M 265M 11.8B | - |
| Net income | 2.35M 2.06M 1.92M 1.77M 3.31M 225M 3.37M 22.8M 8.93M 111M 8.83M 8.64M 385M | - |
| Net Debt | - | - |
Employees
-
Sector
Construction Materials
















